Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Ovarian cancer

  • You have access
    The Tumor Suppressor MicroRNA-1 Exhibits Restricted Inhibition of Proliferation of Ovarian Cancer Cells
    MATTHIAS B. STOPE, DARIA HETTENBACH, ANNE KAUL, MADELEINE PADITZ, KAROLINE DIESING, MARTIN BURCHARDT, MAREK ZYGMUNT, ALEXANDER MUSTEA and DOMINIQUE KOENSGEN
    Anticancer Research July 2016, 36 (7) 3329-3334;
  • You have access
    Synthesis of tris(quinoline)monochloroplatinum(II) Chloride and its Activity Alone and in Combination with Capsaicin and Curcumin in Human Ovarian Cancer Cell Lines
    LAILA ARZUMAN, PHILIP BEALE, JUN Q. YU and FAZLUL HUQ
    Anticancer Research June 2016, 36 (6) 2809-2818;
  • You have access
    Histone Deacetylase-1-mediated Suppression of FAS in Chemoresistant Ovarian Cancer Cells
    ERCAN CACAN
    Anticancer Research June 2016, 36 (6) 2819-2826;
  • You have access
    Impact of Chemotherapy on Retroperitoneal Lymph Nodes in Ovarian Cancer
    MIGNON-DENISE KEYVER-PAIK, JANNE MYRIAM ARDEN, CHRISTINE LÜDERS, THORE THIESLER, ALINA ABRAMIAN, TOBIAS HOELLER, THOMAS HECKING, TIYASHA HOSNE AYUB, ANNA DOESER, CHRISTINA KAISER and WALTHER KUHN
    Anticancer Research April 2016, 36 (4) 1815-1824;
  • You have access
    Role of IGF-I in Primary Ovarian Cancer – A Study of the OVCAD European Consortium
    IRENA ROHR, ROBERT ZEILLINGER, MICHAELA HEINRICH, NICOLE CONCIN, IGNACE VERGOTE, MANI NASSIR, SVEN MAHNER, ELS VAN NIEUWENHUYSEN, FABIAN TRILLSCH, DAN CACSIRE-TONG, RADOSLAV CHEKEROV, JALID SEHOULI and ELENA I. BRAICU
    Anticancer Research March 2016, 36 (3) 1015-1022;
  • You have access
    Inhibitory Effects of the Four Main Theaflavin Derivatives Found in Black Tea on Ovarian Cancer Cells
    YING GAO, GARY O. RANKIN, YOUYING TU and YI CHARLIE CHEN
    Anticancer Research February 2016, 36 (2) 643-651;
  • You have access
    L-Carnosine Prevents the Pro-cancerogenic Activity of Senescent Peritoneal Mesothelium Towards Ovarian Cancer Cells
    JUSTYNA MIKUŁA-PIETRASIK and KRZYSZTOF KSIĄŻEK
    Anticancer Research February 2016, 36 (2) 665-671;
  • You have access
    Pressurized Intraperitoneal Aerosol Chemotherapy with Cisplatin and Doxorubicin in Women with Peritoneal Carcinomatosis: A Cohort Study
    CLEMENS B. TEMPFER, GÜNTHER A. REZNICZEK, PAULA ENDE, WIEBKE SOLASS and MARC-ANDRÉ REYMOND
    Anticancer Research December 2015, 35 (12) 6723-6729;
  • You have access
    Treosulfan in the Treatment of Advanced Ovarian Cancer - Results of a German Multicenter Non-interventional Study
    RADOSLAV CHEKEROV, GABRIELE KALTENECKER, DIETMAR REICHERT, THOMAS GÖHLER, PETER KLARE, GÜLTEN OSKAY-ÖZCELIK, UWE SAUER, ARTHUR WISCHNIK, URSULA VEHLING-KAISER, MARTIN BECKER, ULRICH HUTZSCHENREUTER, ANDREAS AMMON, ELKE HEIDRICH-LORSBACH and JALID SEHOULI
    Anticancer Research December 2015, 35 (12) 6869-6875;
  • You have access
    Antitumor Activity of 3-Indolylmethanamines 31B and PS121912
    MARGARET L. GUTHRIE, PREETPAL S. SIDHU, EMILY K. HILL, TIMOTHY C. HORAN, PREMCHENDAR NANDHIKONDA, KELLY A. TESKE, NINA Y. YUAN, MARINA SIDORKO, REVATHI RODALI, JAMES M. COOK, LANLAN HAN, NICHOLAS R. SILVAGGI, DANIEL D. BIKLE, RICHARD G. MOORE, RAKESH K. SINGH and LEGGY A. ARNOLD
    Anticancer Research November 2015, 35 (11) 6001-6007;

Pages

  • Previous
  • Next
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 20
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire